Gitnux/Report 2026

Animal Health Industry Statistics

The global animal health market reached $75.3B in 2026, explore the figures behind growth, companies and trends.
230Statistics
78Sources
12Sections
1Visuals
43mRead
Animal Health Industry Statistics
Samuel NorbergWritten by Samuel Norberg·Fact-checked by Maya Johansson
Published
How this report is researched
01Editorial Scope

Before any source is gathered, an editor locks the question, what qualifies, and how the piece will be judged.

02Source Research

Search agents collect the source set and pull each data point out with its provenance attached.

Read our full methodology →

Search agents attach provenance to every extracted figure.

Next review: within 31 days

01 Industry overview

The animal health industry at a glance

The global animal health market was estimated at $75.3 billion in 2026, with growth supported by companion-animal spending, livestock disease prevention, diagnostics and biologics adoption.

$75.3B[67]
Global market estimate, 2026
11.0%[67]
Forecast CAGR, 2026–2033
35.0%[67]
North America share, 2025
$9.5B[12]
Zoetis revenue, 2025
Market size
Grand View Research estimated the global animal health market at $68.7 billion in 2025 and $75.3 billion in 2026. The estimate covers biologics, pharmaceuticals, diagnostics, distribution channels, companion animals and production animals.[67]
Forecast & CAGR
The market is forecast to reach $156.0 billion by 2033, representing an 11.0% CAGR from 2026 to 2033. A separate 2025 industry forecast estimated growth from $59.77 billion in 2025 to $89.45 billion in 2030 at an 8.5% CAGR, reflecting differences in market definitions.[67][68]
Market share & regions
North America accounted for 35.0% of global animal health revenue in 2025, according to Grand View Research. AnimalhealthEurope, using CEESA data, reported 2025 animal-medicines sales shares of 41.4% for North America, 30.1% for Europe, 14.7% for Asia-Pacific, 12.2% for Latin America and 1.6% for the Middle East and North Africa.[67][69]
Segmentation
The market is segmented by product, including biologics, pharmaceuticals and diagnostics; by animal, including companion and production animals; and by distribution channel, including retail and e-commerce. The broader industry also includes vaccines, feed additives, equipment and disposables.[67][68]
Key players & concentration
The leading global companies include Zoetis, Merck Animal Health, Boehringer Ingelheim, Elanco Animal Health and IDEXX Laboratories. One 2025 market estimate placed the combined share of these five companies at 40%; Zoetis separately reported $9.5 billion in 2025 revenue.[70][12]
Pricing
Veterinary-care prices have risen faster than general inflation in several developed markets. In the United Kingdom, average prices at five large veterinary groups were 18.3% higher than at independent practices between January 2023 and July 2024, according to the House of Commons Library.[71]
Trends, drivers & challenges
Demand is being driven by pet humanization, higher animal-health spending, zoonotic-disease concerns, livestock production and adoption of diagnostics and artificial intelligence. WOAH reported that more than 20% of global animal production is lost to disease each year, while avian-influenza outbreaks in 2025 and early 2026 involved 2,121 outbreaks and 140 million animals dead or culled.[67][24]
Consumer behavior & competition
Companion-animal demand is supported by higher spending on preventive care, diagnostics and chronic-disease treatment, while affordability is becoming a constraint. In the United Kingdom, more than 60% of approximately 5,000 veterinary practices were wholly or partly owned by six large veterinary groups, indicating increasing concentration in the care-delivery channel.[71][67]
M&A
Distribution and technology consolidation continued in 2026: Cencora and Covetrus announced an agreement to merge Covetrus with MWI Animal Health, valuing MWI at an enterprise value of $3.5 billion. The transaction is intended to combine companion-animal and production-animal distribution with technology platforms.[21]
Regulation
FDA approved 14 new animal drugs in fiscal 2025, comprising 12 full approvals and two conditional approvals. From fiscal 2018 through 2025, FDA conditionally approved 11 new animal drugs, while the Government Accountability Office identified limits in the five-year conditional-approval framework as a policy issue.[72]
Latest news
In 2026, WOAH’s State of the World’s Animal Health report highlighted a $2.3 billion annual financing gap needed to bring global Veterinary Services to standard and recorded 2,121 avian-influenza outbreaks during 2025 and early 2026. Separately, the proposed $3.5 billion MWI–Covetrus transaction underscored continued consolidation in animal-health distribution.[24][21]

02 Ranking

Top 10 Companies in the Animal Health Industry

The leading companies in the animal health industry, ranked on market impact, performance, momentum, innovation and brand popularity.

Updated November 11, 2026 · Next review December 11, 2026

Verdict

Zoetis stands out for animal medicines, vaccines, diagnostics and technologies because it makes medicines, vaccines, diagnostics and technologies for pets and farm animals, while Merck leads in livestock and companion-animal products since its Animal Health segment sells livestock and companion-animal products globally.

Ranked by Overall score · How we score ↓

Editor's top 3 picks

Where to start, by need.

  1. #1 Overall · Leader in veterinary medicines

    Zoetis

    US

    Ranked #1 · 9.2 · Veterinary medicines

    Why we picked it: It combines animal medicines, vaccines, diagnostics and devices, and reported an 81.6% gross margin in 2024.

    See in ranking ↓Visit zoetis.com ↗

  2. Leader in veterinary vaccines

    HIPRA

    ES

    Ranked #3 · 9.1 · Veterinary vaccines

    Why we picked it: It develops and manufactures vaccines and biological products for animal health, with a reported 17% revenue growth.

    See in ranking ↓Visit hipra.com ↗

  3. Leader in veterinary diagnostics

    IDEXX Laboratories

    US

    Ranked #5 · 9.1 · Veterinary diagnostics

    Why we picked it: It provides diagnostic products, reference laboratories and systems for veterinary practices, with a 31.6% operating margin.

    See in ranking ↓Visit idexx.com ↗

Pick 1 is the #1 company overall. Picks 2 and 3 are the highest-ranked companies in the top 5 that add a new segment.

Full ranking

Sort by
Top 10 companies in the animal health industry, 2026 – Gitnux ranking
#CompanyOverall ↓Company snapshot
1

Zoetis

Veterinary medicines · US

9.2
2

Merck

Veterinary medicines · US

9.2
3

HIPRA

Veterinary vaccines · ES

9.1
4

Huvepharma

Veterinary medicines · BG

9.1
5

IDEXX Laboratories

Veterinary diagnostics · US

9.1
6

Biogénesis Bagó

Livestock vaccines and pharmaceuticals · AR

9.0
7

Dechra Pharmaceuticals

Specialty veterinary pharmaceuticals · GB

8.9
8

Ceva Santé Animale

Veterinary vaccines and pharmaceuticals · FR

8.7
9

Vetoquinol

Veterinary medicines for pets and livestock · FR

8.3
10

Ourofino Saúde Animal

Veterinary medicines for livestock and pets · BR

8.3

How we score

  • Impact (30%): scale and weight in the market (revenue, market share, employees, market position).
  • Performance (20%): recent revenue growth and operating margin; an analyst assessment where a company does not publish them.
  • Momentum (20%): growth trajectory and future potential.
  • Innovation (15%): R&D intensity and how technologically advanced the company is.

Popularity (brand search demand, 15%) counts toward Overall but is not published as a column. Overall leaves out what is not known.

Scale Scores are shown on a 7–10 scale with one decimal; bars start at 7.0.

Cadence Recalculated when new figures are published; next review December 11, 2026.

Independence. Rankings are editorially independent. Scores, ranks, picks and the verdict follow the method above; no company can pay to change them.

Cite this ranking

APA

Samuel Norberg. (2026, November 11). Top 10 companies in the animal health industry. In Animal Health Industry Statistics. Gitnux. https://gitnux.org/animal-health-industry-statistics/#top-companies

report visual · Comparison

Global animal health product sales by product category

Parasiticides holds the largest share at 33.6%.

Parasiticides33.6%
Vaccines28.1%
Other products24.7%
Antimicrobials13.7%
source-verifiedahi.org

04 Statistics

Technology & Innovation

AI adoption is moving from evaluation into documentation and clinical workflows. In 2026, 48% of U.S. general veterinary practices used AI in some form and 75% of those reported increased efficiency.

AI in the animal health industry

  • 48% of U.S. general veterinary practices used AI in some form in 2026, and 75% of those practices reported increased efficiency.[1]
  • 49% of veterinary professionals surveyed in 2025 said their practice had not integrated AI or machine learning, down from 57% in 2024.[2]
  • 63% of U.S. general veterinary practices using AI reported medical-record or SOAP-note creation as an application, while 38% reported diagnostic assistance in 2026.[1]
  • 20% of UK veterinary surgeons working in clinical practice reported using AI tools in 2025.[3]
  • 62.8% of AI-using veterinary professionals reported using AI for clinical documentation, including AI scribes and SOAP notes, in 2026.[4]
  • 83.7% of veterinary professionals in the United States and Canada used AI in 2026, up from 39.2% in 2024.[4]

Digital Transformation in the healthcare services sector (sector benchmark)

  • About 90% of surveyed global healthcare C-suite executives expected digital technology use to accelerate in 2025, including 50% anticipating a significant impact.[5]
  • About 70% of surveyed healthcare executives said investing in technology platforms for digital tools and services would be important or very important in 2025.[5]
  • Among healthcare respondents to KPMG’s global technology survey, 49% were adopting DevSecOps approaches to adapt digital-transformation strategies.[6]
  • Across U.S. non-federal acute care hospitals, 71% used predictive AI integrated into electronic health records in 2024.[7]
  • Across surveyed healthcare practitioners, 60% believed their organizations’ digital experiences met or exceeded customer needs in 2025.[8]

Technology Adoption in the healthcare services sector (sector benchmark)

  • Across U.S. non-federal acute care hospitals, 96% enabled patients to download health information electronically in 2024.[7]
  • Across U.S. non-federal acute care hospitals, 99% enabled patients to view health information electronically in 2024.[7]
  • Across U.S. non-federal acute care hospitals, 92% enabled patients to securely message providers in 2024.[7]
  • Across U.S. non-federal acute care hospitals, 81% enabled patient access through applications using application-programming-interface specifications in 2024.[7]
  • Across U.S. non-federal acute care hospitals, 70% enabled patient access through applications using HL7 FHIR specifications in 2024.[7]
  • Across U.S. non-federal acute care hospitals, 84% enabled patients to transmit health information to a third party electronically in 2024.[7]

Cloud Computing in the healthcare services sector (sector benchmark)

  • Across surveyed healthcare organizations globally, 27% reported that cloud operations were well managed and integrated into overall IT strategy at the end of 2025.[9]
  • Across surveyed healthcare organizations globally, 31% had a formal cloud strategy and governance framework that was not yet integrated into IT strategy at the end of 2025.[9]
  • Across surveyed healthcare organizations globally, 18% had started adopting cloud services but lacked a comprehensive cloud strategy at the end of 2025.[9]
  • Across surveyed healthcare organizations globally, 15% reported that cloud adoption was fully integrated into business strategy at the end of 2025.[9]
  • Across surveyed healthcare organizations globally, 8% reported minimal cloud adoption without formal strategy or governance at the end of 2025.[9]

Big Data in the healthcare services sector (sector benchmark)

  • Across Brazilian healthcare facilities conducting Big Data analytics, 65% used patient demographics, forms, or medical-record data in 2024.[10]
  • Across Brazilian healthcare facilities conducting Big Data analytics, 38% used geolocation data from mobile phones, wireless connections, or GPS in 2024.[10]
  • Across Brazilian healthcare facilities conducting Big Data analytics, 72% used data from smart devices or sensors in 2024.[10]
  • Across Brazilian healthcare facilities conducting Big Data analytics, 48% used social-media data in 2024.[10]
  • Across Brazilian healthcare facilities conducting Big Data analytics, 77% used in-house staff rather than external providers in 2024.[10]

IoT in the healthcare services sector (sector benchmark)

  • Among Brazilian inpatient healthcare facilities with more than 50 beds and internet access, 19% used IoT in 2024.[11]
  • Among Brazilian inpatient healthcare facilities with up to 50 beds and internet access, 5% used IoT in 2024.[11]
  • Among Brazilian private healthcare facilities with internet access, 6% used IoT in 2024.[11]

05 Statistics

Data & Analytics

Analytics work concentrates on decision support and research acceleration. Zoetis reports that AI was used in 2025 to accelerate discovery and enhance target validation.

Business intelligence in the animal health industry

  • AI was being used by Zoetis in 2025 to accelerate discovery and enhance target validation in animal-health research.[12]
  • 75+ years of proprietary research data supported Zoetis’s animal-health R&D and decision-making platform as of 2025.[12]
  • More than 12 potential blockbuster candidates were in Zoetis’s pipeline in 2025 across chronic kidney disease, oncology, cardiology, anxiety and obesity.[13]

Data analytics in the animal health industry

  • 4.1% of studies in the same 2025 review focused on information and knowledge sharing as a digital-tool application in livestock production.[14]
  • 23.3% of studies in a 2025 systematic review of digital livestock tools focused on wearable technologies for collecting animal-health and behavior data.[14]
  • 14 years of antimicrobial-resistance data from rural and regional veterinary practices in Texas, covering 2011–2024, were used to support analytics and decision-making.[15]

Data Quality in the healthcare services sector (sector benchmark)

  • 75% of U.S. healthcare organizations represented in the survey predominantly used clinical registry data for quality and process improvement in 2024.[16]
  • 50% of U.S. healthcare clinical data abstractors reported that data inaccuracies hamper clinical registry efforts in 2024.[16]
  • 40% of U.S. healthcare clinical data abstractors reported that incomplete data hampers clinical registry efforts in 2024.[16]
  • 8% of U.S. healthcare organizations rated their provider data as excellent in 2022.[17]
  • 40% of U.S. healthcare clinical data abstractors reported that manual data entry hampers clinical registry efforts in 2024.[16]

Data Governance in the healthcare services sector (sector benchmark)

  • 77% of healthcare organizations reported that their governance functions met at least quarterly in 2025.[17]
  • 10% of healthcare organizations managed data governance exclusively within IT in 2025.[17]
  • 66% of healthcare organizations reported multidisciplinary representation in governance, including patient or consumer representatives, in 2025.[17]
  • 39% of healthcare organizations reported having a formally chartered data-governance function in 2025.[17]
  • 38% of healthcare organizations had formal data and information quality-management statements in 2025.[17]
  • 72% of healthcare organizations operated governance using approved policy and standards frameworks in 2025.[17]

KPIs in the animal health industry

  • $9.3 billion was Zoetis’s reported revenue in 2024, one of its principal company-level performance indicators for the animal-health business.[12]
  • 13,800 colleagues worked at Zoetis in 2024, a workforce KPI reported in its animal-health sustainability progress update.[12]
  • 22 global manufacturing sites were operated by Zoetis in 2024 as part of its animal-health supply and operations footprint.[12]

06 Statistics

Strategy & Growth

Scale and portfolio mix shape company results as market demand expands. The global animal-health market is forecast to reach $156.0 billion by 2033 at an 11.0% CAGR from 2026 to 2033.

Growth in the animal health industry

  • The global animal-health market was projected to grow at an 8.5% compound annual rate from 2022 to 2030.[18]
  • Zoetis generated $9.3 billion in animal-health revenue in 2024, up 8% from 2023 on a reported basis.[19]
  • The global animal-health market grew from €39.0 billion in 2017 to €55.9 billion in 2022, equivalent to a 7.5% compound annual growth rate.[18]
  • Zoetis’ companion-animal portfolio grew 14% operationally and its livestock portfolio grew 5% operationally in 2024.[19]

Differentiation in the animal health industry

  • Animal-health diagnostics represented 4% of Zoetis’ 2024 revenue by product category.[12]
  • Parasiticides represented 24% of Zoetis’ 2024 revenue by product category, the company’s largest product-category share.[12]
  • Dogs and cats generated 65% of Zoetis’ 2024 revenue by species, compared with 17% from cattle and 6% from poultry.[12]
  • 55% of Zoetis’ 2024 revenue came from its ten largest product lines, while its five largest product lines accounted for 41%.[12]

Mergers and acquisitions in the animal health industry

  • Europe and North America accounted for 85% of global animal-health M&A activity from 2021 through 2025.[20]
  • 406 global animal-health transactions were recorded in 2025, 46% more than in 2021 and within 7% of the 2022 peak.[20]
  • Private-equity funds and private-equity-backed platforms accounted for 54% of global animal-health acquirers in 2025.[20]
  • Approximately 220 private-equity-led animal-health deals were completed globally in 2025.[20]

Strategic partnerships in the animal health industry

  • Covetrus’ renewed 2024 distribution partnership designated it the leading in-clinic veterinary-products supplier for NVA and Ethos hospitals across the United States.[21]
  • Ceva and Touchlight signed a long-term collaboration in 2025 covering development and manufacture of dbDNA vaccines and therapeutics across a broad range of animal-health indications.[22]

07 Statistics

People & Workforce

Workforce capacity constraints show up across clinical settings. WOAH assessed 93% of 43 member veterinary services as lacking sufficient workforce capacity through the PVS pathway.

Hiring in the animal health industry

  • More than 50% of specialty, emergency and urgent-care veterinary practices hired additional full-time staff in 2025.[23]
  • 85% of specialty, emergency and urgent-care veterinary practices cited staffing shortages as their most widely reported challenge in 2025.[23]
  • 93% of 43 WOAH Member veterinary services assessed through the PVS pathway lacked sufficient workforce capacity.[24]
  • 32% of specialty, emergency and urgent-care veterinary practices reported working longer hours despite hiring efforts in 2025.[23]

Employee retention in the animal health industry

  • 52% of U.S. general veterinary practices reported no significant staff turnover during 2025.[1]
  • 48% of U.S. general veterinary practices increased pay during 2025, compared with 70% that identified better compensation as a retention improvement.[1]
  • 70% of U.S. general veterinary practices said better compensation would improve employee retention in 2025.[1]
  • 30% of U.S. general veterinary practices reported losing nurses, technicians or assistants during 2025.[1]

Remote Work in the healthcare services sector (sector benchmark)

  • Across U.S. medical groups, 22% of leaders expected their organization’s share of remote or hybrid jobs to increase during 2024.[25]
  • Across U.S. medical groups, 52% reported that 1%–25% of their workforce worked remotely at least 50% of the time.[25]
  • Across U.S. health care and social assistance, 18% of full-time employees worked fully from home during December 2024–March 2025.[26]
  • Across U.S. medical groups, 18% of leaders expected their organization’s share of remote or hybrid jobs to decrease during 2024.[25]

Hybrid Work in the healthcare services sector (sector benchmark)

  • Across U.S. healthcare support roles, 14% had part-time remote availability, equivalent to hybrid availability, in the 2022 McKinsey American Opportunity Survey.[25]
  • About 12% of nonclinical healthcare administrative and customer-support jobs were hybrid in a 2024 Robert Half survey cited by the Medical Group Management Association.[25]
  • About 6% of U.S. healthcare jobs were hybrid in a 2024 Robert Half survey cited by the Medical Group Management Association.[25]
  • Across U.S. health care and social assistance, 24% of full-time employees were in hybrid arrangements during December 2024–March 2025.[26]
  • Across U.S. healthcare practitioners and technical roles, 16% had part-time remote availability, equivalent to hybrid availability, in the 2022 McKinsey American Opportunity Survey.[25]

Employee Engagement in the healthcare services sector (sector benchmark)

  • Across 2.3 million U.S. healthcare workers, employee engagement declined by 0.02 points in 2024.[27]
  • Across U.S. healthcare organizations, employee turnover fell from 20% to 18% in 2024.[27]
  • Across NHS staff, the national staff-engagement theme score was 6.64 in the second quarter of 2024/25.[28]
  • Across U.S. healthcare workers, 78% believed their organization cared about their safety in 2024.[27]
  • Among U.S. healthcare advanced practice providers, 52% felt heard in 2024.[27]

DEI in the animal health industry

  • 69% of veterinarians, 90% of veterinary technicians and 80% of veterinary assistants and laboratory-animal workers in the United States were women, according to NIOSH data.[29]
  • 74.28% of the U.S. laboratory-animal veterinary workforce identified as White or Caucasian in 2024.[30]
  • 70.29% of the U.S. laboratory-animal veterinary workforce were women in 2024.[30]
  • 83.6% of the U.S. veterinary-services workforce were women in 2024.[31]

Change Management in the healthcare services sector (sector benchmark)

  • Across 36 healthcare transformation studies, 64% reported successful transformation, 6% reported partial success, and 17% reported unsuccessful transformation.[32]
  • Among 31 healthcare transformation studies excluding varied-success comparisons, 74% reported full success.[32]
  • Among U.S. healthcare transformation studies, 88% reported successful transformation.[32]
  • Among Canadian healthcare transformation studies, 40% reported successful transformation and 60% reported either success or partial success.[32]

08 Statistics

Customer & Sales

Customer experience in the animal health industry

  • 73% of UK pet owners ranked trust in the veterinarian as the most important factor when choosing a veterinary practice in 2026.[33]
  • 29.2% of U.S. veterinary practices offered telehealth in 2024.[30]
  • 58% of UK pet owners ranked location among the most important factors when choosing a veterinary practice in 2026.[33]
  • 33.4% of U.S. veterinary practices offered online appointment scheduling in 2024.[30]
  • 49% of UK pet owners ranked customer service among the most important factors when choosing a veterinary practice in 2026.[33]

Customer retention in the animal health industry

  • 63% of veterinary practices across the United States, United Kingdom, Spain and Italy agreed that clients were no longer loyal to one clinic in 2025.[34]
  • 31% of U.S. pet owners said they were likely to change veterinary clinics in 2025.[35]
  • 40% of U.S. pet owners aged 18 to 34 said they were likely to change veterinary clinics in 2025.[35]
  • 61% of U.S. veterinary hospitals perceived a decline in client loyalty in 2025.[35]

Customer loyalty in the animal health industry

  • 65.4% to 67.5% was the client-bonding-rate range for Veterinary Hospital Managers Association practices during the 12 months through October 2024.[35]
  • 318,693 veterinary client-satisfaction surveys were analyzed to evaluate client loyalty and satisfaction across four practice types from 2018 through 2022.[36]
  • 62.5% to 64.7% was the client-bonding-rate range for non-Veterinary Hospital Managers Association practices during the 12 months through October 2024.[35]

09 Statistics

Marketing & Brand

B2C information channels split between traditional advertising and reviews, while practice and conference participation supports measurable reach. AAHA represented 4,500+ veterinary practices and influenced more than $2 billion in annual spending in 2024.

Marketing in the animal health industry

  • 40% of U.S. pet parents used traditional advertising to obtain information about pet products and brands in 2023.[37]
  • 4,500+ veterinary practices were represented by AAHA, whose members influence more than $2 billion in annual spending on veterinary equipment and pharmaceuticals in 2024.[38]
  • 29% of U.S. pet parents used review sites to discover pet products or brands in 2023.[37]
  • 24% of U.S. pet parents used digital advertising to discover pet products or brands in 2023.[37]

Digital marketing in the animal health industry

  • 4.6% was Animal Health Australia’s average social-media engagement rate in fiscal 2022–23, compared with 2% reported as the industry average.[39]
  • 275,471 pageviews were generated by an Animal Health Australia producer emergency-animal-disease awareness campaign in fiscal 2022–23.[39]
  • 7,000+ veterinary professionals registered for AAHA webinars in 2024, providing a measurable digital channel for veterinary-industry marketing.[38]
  • 11,927 click-throughs were generated from Animal Health Australia social-media posts in fiscal 2022–23.[39]

Branding in the animal health industry

  • 69% of U.S. Gen Z cat owners said brand name was important or very important when purchasing pet products in 2024.[40]
  • 70% of U.S. millennial cat owners said brand name was important or very important when purchasing pet products in 2024.[40]
  • 67% of U.S. millennial dog owners said brand name was important or very important when purchasing pet products in 2024.[40]
  • 73% of U.S. Gen Z dog owners said brand name was important or very important when purchasing pet products in 2024.[40]

Social media in the animal health industry

  • 33% of European veterinarians used social media to inform or educate clients in 2023.[41]
  • 15,035 followers were reached by Animal Health Australia’s Twitter, Facebook and LinkedIn accounts in fiscal 2022–23, representing 23.7% growth.[39]
  • 1,142 posts were published across Animal Health Australia’s Twitter, Facebook and LinkedIn accounts in fiscal 2022–23.[39]
  • 936,354 accounts were reached by Animal Health Australia social-media activity in fiscal 2022–23.[39]

Influencer Marketing in the healthcare services sector (sector benchmark)

  • 50% of healthcare and pharmaceutical marketers reported dedicated, growing creator/influencer budgets in 2026, compared with 58% globally.[42]
  • 8.57 million influencer posts about the health industry generated a 1.07% average engagement rate globally in 2023.[43]
  • 50% of U.S. physicians surveyed had changed prescribing choices based on healthcare influencer or KOL content on social media in 2024.[44]
  • 33% of U.S.-focused health and wellness influencers promoted a product, service or subscription in more than half of their posts in 2026.[45]
  • 92% of U.S.-focused health and wellness influencers included product or service promotions at least occasionally in 2026.[45]

10 Statistics

Operations & Execution

Operational performance targets are tracked through turnaround time and licensing throughput. For APHA, 100% of import licences were issued within agreed timeframes in each quarter of fiscal 2024–25.

Process optimization in the animal health industry

  • 97% of APHA non-trade laboratory tests met the published turnaround-time standard in the fourth quarter of fiscal 2024–25.[46]
  • 99% of APHA trade laboratory tests met the published turnaround-time standard in each quarter of fiscal 2024–25.[46]
  • 100% of APHA import licences were issued within agreed timeframes in each quarter of fiscal 2024–25.[46]
  • 97% of APHA export certificates and licences were progressed within required timescales and standards in the fourth quarter of fiscal 2024–25.[46]

Operational efficiency in the animal health industry

  • $2 billion in pre-tax run-rate savings was targeted by Zoetis by the end of 2025 under its global cost-reduction program.[47]
  • $835 million in pre-tax run-rate savings had been achieved by Zoetis through the end of 2023 under its global cost-reduction program.[47]
  • $1.5 billion in pre-tax run-rate savings was targeted by Zoetis by the end of 2024 through cost and supply-chain initiatives.[47]
  • 3.3 percentage points was Virbac’s profitability uplift in the first half of 2024.[48]

Quality management in the animal health industry

  • 90% was APHA’s target for initiating animal-disease tracing within 10 working days in fiscal 2024–25; quarterly performance reached 100%, 100%, 62% and 100%.[46]
  • 99% of APHA trade laboratory tests met published turnaround times in the fourth quarter of fiscal 2024–25.[46]
  • 96% was APHA’s target for visiting avian-influenza cases within 24 hours in fiscal 2024–25, with the target met in all four quarters.[46]
  • 90% was APHA’s target for removing disease cases from breakdown herds within 10 working days in fiscal 2024–25; quarterly performance ranged from 87% to 97%.[46]

Supply chain in the animal health industry

  • 76% of highest-risk listed plant-material import consignments were inspected by APHA in the fourth quarter of fiscal 2024–25.[46]
  • $1.5 billion of Zoetis’s targeted $2 billion in 2025 savings was expected to come from supply-chain transformation.[47]
  • $1.294 billion in cash proceeds was received by Elanco from the sale of its aqua business in July 2024.[47]
  • 100% of APHA import licences were issued within agreed timeframes in every quarter of fiscal 2024–25.[46]

Outsourcing / Offshoring in the healthcare services sector (sector benchmark)

  • 46% of global healthcare providers used third-party providers for customer-experience services in 2024, based on a survey of 28 healthcare-provider executives.[49]
  • 43% of global healthcare providers used third-party providers for payroll services in 2024, based on a survey of 28 healthcare-provider executives.[49]
  • 54% of global healthcare providers used third-party providers for supply-chain services in 2024, based on a survey of 28 healthcare-provider executives.[49]
  • 18% of U.S. medical-group leaders planned to outsource or automate patient communications in contact centers in 2024, according to an MGMA poll with 262 responses.[25]
  • 29% of global healthcare providers used third-party providers for remote patient monitoring in 2024, based on a survey of 28 healthcare-provider executives.[49]

11 Statistics

Finance & Pricing

Profitability and margin metrics vary across company models. Zoetis reported an 81.6% gross margin in 2024, while IDEXX reported a 31.6% operating margin.

Pricing strategy in the animal health industry

  • 3% pricing growth increased Elanco’s 2024 pet-health revenue, partially offset by slightly lower volumes.[47]
  • $39 million was Elanco’s increase in pet-health revenue in 2024, supported by 3% pricing growth.[50]

Cost reduction in the animal health industry

  • $275 million to $300 million in cost synergies was identified by Elanco from the Bayer Animal Health acquisition by the end of 2025.[51]
  • $2 billion was Zoetis’s 2025 target for pre-tax run-rate cost savings under its global cost-reduction program.[47]
  • $835 million in pre-tax run-rate savings was achieved by Zoetis in 2023 through headcount, indirect-spend and supply-chain actions.[47]
  • $1.5 billion was Zoetis’s 2024 target for pre-tax run-rate cost savings under its global cost-reduction program.[47]

Profitability in the animal health industry

  • $338 million was Elanco’s net income in 2024, compared with a $1.231 billion net loss in 2023.[47]
  • $2.436 billion was Elanco’s gross profit in 2024, producing a 54.9% gross margin on $4.439 billion of revenue.[47]
  • 81.6% was Zoetis’s gross margin in 2024.[52]
  • $280.3 million was Virbac’s 2024 operating cash flow.[48]

Financial planning in the animal health industry

  • $4.439 billion was Elanco’s 2024 revenue, including $2.143 billion from pet health and $2.250 billion from farm animal products.[47]
  • $9.3 billion was Zoetis’s annual revenue in 2024, supporting planning across more than 100 countries.[47]
  • $706.482 million was Phibro Animal Health’s animal-health revenue for the year ended June 30, 2024.[47]
  • 13,800 colleagues worked for Zoetis as of December 31, 2024, a workforce scale relevant to animal-health financial planning.[47]

12 Statistics

Product & Service

R&D allocation and product pipeline depth are used as planning inputs. Zoetis reported $686 million in R&D investment in 2024 and 2,000+ new products and lifecycle innovations introduced over 13 years ending December 31, 2025.

Product development in the animal health industry

  • ECO Animal Health spent £8.6 million on research and development in 2025, compared with £8.3 million in 2024, primarily on late-stage vaccine assets.[53]
  • 1,600 R&D colleagues worked at Zoetis in 2024 across its global animal-health product-development organization.[12]
  • More than $6 billion had been invested in Zoetis R&D since 2013 by December 31, 2025, supporting animal-health medicines, vaccines, diagnostics and devices worldwide.[12]
  • 90 therapeutic targets and 15 therapeutic areas were covered by Zoetis’s R&D activities as of December 31, 2025.[12]
  • $686 million was Zoetis’s R&D investment in 2024, the animal-health company’s largest annual R&D expense, globally.[12]

Product lifecycle in the animal health industry

  • 40%–50% of Zoetis’s projected new R&D revenue is expected to come from new product innovation that substantially enhances standards of care.[12]
  • 35%–40% of Zoetis’s projected new R&D revenue is expected to come from lifecycle innovation, including new species, formulations, indications and combinations.[12]
  • Elanco reported that 2024 product development included new molecules, additional registrations and new indications for existing animal-health products worldwide.[51]
  • 2,000+ new products and lifecycle innovations had been introduced by Zoetis during the 13 years ending December 31, 2025.[12]
  • 15%–20% of Zoetis’s projected new R&D revenue is expected to come from geographic expansion of existing animal-health products.[12]

After-sales in the animal health industry

  • 4,050 sales-organization colleagues supported Zoetis customers in 2024, including sales representatives and veterinary technical representatives.[12]
  • 3,900 field-force members supported Zoetis customers globally as of December 31, 2025, providing commercial and technical service for animal-health products.[12]

Value proposition in the animal health industry

  • $9.3 billion was Zoetis’s animal-health revenue in 2024, generated from medicines, vaccines, diagnostics, devices and precision-animal-health solutions.[19]
  • 70% of Zoetis’s 2025 revenue came from companion-animal products and 30% from livestock products, excluding client supply services and human health.[12]
  • Zoetis products were sold in more than 100 countries in 2025, supporting customers across eight core animal species.[12]
  • Elanco’s animal-health portfolio was sold in more than 90 countries in 2024 and served companion animals and farm animals across multiple species.[51]

13 Statistics

Sustainability & Ethics

Reported environmental targets and workforce safety disclosures sit alongside education funding. Zoetis funded nearly 500 veterinary-student scholarships in 2024 through $3.5 million.

Sustainability in the animal health industry

  • $3.5 million in Zoetis funding provided nearly 500 veterinary-student scholarships in 2024.[13]
  • 33% of Axiota Animal Health’s waste was recycled or composted in 2023, according to Paine Schwartz Partners’ portfolio sustainability data.[54]
  • 15 Zoetis manufacturing sites, its Kalamazoo R&D headquarters and its Dublin international headquarters were covered by renewable electricity in 2024.[13]

ESG in the animal health industry

  • 175,807 metric tons of Scope 1 greenhouse-gas emissions were reported by Elanco in 2024.[55]
  • Zero work-related fatalities were reported by Elanco for 2024 in its impact-report workforce-safety disclosures.[55]
  • 302,607 metric tons of market-based Scope 2 greenhouse-gas emissions were reported by Elanco in 2024.[55]
  • 496,505 metric tons of Scope 3 greenhouse-gas emissions were reported by Elanco in 2024.[55]

CSR in the animal health industry

  • $9.3 billion in revenue supported Zoetis’s 2024 animal-health business and its associated community, education and access initiatives.[13]
  • 13,800 colleagues were employed by Zoetis in 2024, the workforce base covered by its animal-health community and workplace programs.[12]
  • Nearly 500 veterinary students received scholarships funded by Zoetis’s $3.5 million 2024 grantmaking program.[13]

Circular economy in the animal health industry

  • 33% of Axiota Animal Health’s waste was recycled or composted in 2023, based on portfolio-company sustainability reporting.[54]
  • 80% was the recycling target for veterinary-medicine packaging waste in the evaluated extended-producer-responsibility system, although actual performance remained below target.[32]

Carbon footprint in the animal health industry

  • 1,133 metric tons of combined Scope 1 and Scope 2 greenhouse-gas emissions were reported by Axiota Animal Health in 2023.[54]
  • 550 metric tons of Scope 1 emissions were reported by Axiota Animal Health in 2023.[54]
  • 16 metric tons of Scope 3 waste emissions were reported by Axiota Animal Health in 2023.[54]
  • 584 metric tons of Scope 2 emissions were reported by Axiota Animal Health in 2023.[54]

15 Statistics

Globalization & Expansion

Geographic sales footprint and distribution-channel shares drive planning. North America accounted for 35.0% of global animal health revenue in 2025, and veterinary hospitals and clinics represented 54% of the global distribution-channel market in 2026.

Globalization in the animal health industry

  • Zoetis sold approximately 2,000 product lines in more than 100 countries in 2024.[12]
  • 41.8% of the global animal-health product market was located in North America in 2021, compared with 28.3% in Europe and 18.5% in Asia-Pacific.[63]
  • 55% of Zoetis’ 2024 revenue came from the United States and 44% from international markets, reflecting the company’s global animal-health operating footprint.[12]
  • The global animal-health market was estimated at €55.9 billion in 2022, with projected growth to €107.1 billion by 2030.[18]

Stakeholder management in the animal health industry

  • €360 million was the total funding attached to the European Partnership on Animal Health and Welfare launched in 2024.[64]
  • 90 members from 24 countries participated in the European Partnership on Animal Health and Welfare launched in 2024.[64]
  • More than 1,000 veterinary hospitals, pet resorts, and related facilities were covered by Covetrus’ renewed U.S. distribution partnership with NVA in 2024.[21]
  • €2.5 million was awarded to the University of Surrey for its participation in the European Partnership on Animal Health and Welfare in 2024.[64]

Distribution channels in the animal health industry

  • 54.2% of the U.S. animal-treatment market was sold through veterinary hospitals and clinics in 2025.[65]
  • USD 26.49 billion was the 2024 global animal-health market value attributed to veterinary hospitals and clinics in the cited distribution-channel dataset.[66]
  • USD 15.57 billion was the 2024 global animal-health market value attributed to retail distribution in the cited distribution-channel dataset.[66]
  • 54% of the global animal-health distribution-channel market was represented by veterinary hospitals and clinics in 2026.[66]

Key questions about the animal health industry

What is the current size of the global animal health market?
The global animal health market was estimated at $75.3 billion in 2026.
How fast is the animal health market expected to grow?
The forecast CAGR for 2026–2033 is 11.0%, taking the market from $75.3 billion in 2026 to $156.0 billion by 2033.
Which companies lead the animal health industry?
Zoetis stands out for animal medicines, vaccines, diagnostics and technologies because it makes medicines, vaccines, diagnostics and technologies for pets and farm animals, while Merck leads in livestock and companion-animal products since its Animal Health segment sells livestock and companion-animal products globally.
How are AI and analytics shifting veterinary workflows?
In 2026, 48% of U.S. general veterinary practices used AI in some form, and 75% of those reported increased efficiency. In the same year, 63% reported medical-record or SOAP-note creation, and 38% reported diagnostic assistance.
What does distribution consolidation look like in this industry?
In 2026, Cencora and Covetrus announced an agreement to merge Covetrus with MWI Animal Health, valuing MWI at an enterprise value of $3.5 billion.
What compliance activity is relevant for new animal drugs in the United States?
FDA approved 14 new animal drugs in fiscal 2025, including 12 full approvals and two conditional approvals.
Reference

Cite This Report

This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.

APA
Samuel Norberg. (2026, November 11). Animal Health Industry Statistics. Gitnux. https://gitnux.org/animal-health-industry-statistics
MLA
Samuel Norberg. "Animal Health Industry Statistics." Gitnux, 11 Nov 2026, https://gitnux.org/animal-health-industry-statistics.
Chicago
Samuel Norberg. 2026. "Animal Health Industry Statistics." Gitnux. https://gitnux.org/animal-health-industry-statistics.

Sources & references

78 sources cited across this report

  1. instinct.vet
  2. vetmedux.com
  3. icaew.com
  4. prnewswire.com
  5. deloitte.com
  6. kpmg.com
  7. healthit.gov
  8. business.adobe.com
  9. go.rackspace.com
  10. cetic.br
  11. nic.br
  12. zoetis.com
  13. investor.zoetis.com
  14. doi.org
  15. pmc.ncbi.nlm.nih.gov
  16. carta.healthcare
  17. intersystems.com
  18. storage.mfn.se
  19. news.zoetis.com
  20. investec.com
  21. covetrus.com
  22. ceva.com
  23. animalhealthnews.com
  24. woah.org
  25. mgma.com
  26. wfhresearch.com
  27. pressganey.com
  28. england.nhs.uk
  29. cdc.gov
  30. ebusiness.avma.org
  31. datausa.io
  32. journals.sagepub.com
  33. vettimes.com
  34. provet.cloud
  35. vhma.org
  36. pubmed.ncbi.nlm.nih.gov
  37. fwv-us.com
  38. aaha.org
  39. animalhealthaustralia.com.au
  40. tica.org
  41. scribd.com
  42. brand-news.it
  43. media.sproutsocial.com
  44. sermo.com
  45. pewresearch.org
  46. gov.uk
  47. sec.gov
  48. corporate.virbac.com
  49. tcs.com
  50. publicnow.com
  51. investor.elanco.com
  52. s203.q4cdn.com
  53. ecoanimalhealth.com
  54. paineschwartz.com
  55. sustainabilityreports.com
  56. fda.gov
  57. ache.org
  58. proofpoint.com
  59. ponemonsullivanreport.com
  60. kff.org
  61. hfmmagazine.com
  62. sophos.com
  63. healthforanimals.org
  64. surrey.ac.uk
  65. emergenresearch.com
  66. wantstats.com
  67. grandviewresearch.com
  68. thebusinessresearchcompany.com
  69. animalhealtheurope.eu
  70. gminsights.com
  71. commonslibrary.parliament.uk
  72. gao.gov
  73. merck.com
  74. ir.idexx.com
  75. vetoquinol.com
  76. americanpetproducts.org
  77. iii.org
  78. idexxproxymaterials.com